Company intelligence / Profile preview

Vector Biolabs

Malvern, Pennsylvania, United Statesvectorbiolabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vector Biolabs does not develop its own therapeutics but enables thousands of academic labs, biopharma companies, and CROs with high-quality viral vectors referenced in over five thousand peer-reviewed publications. Their products support discovery through IND-enabling studies.

Therapeutic areas: Other
Modalities: Gene therapyViral vector (Adenovirus)Viral vector (AAV/adeno-associated virus)Short hairpin RNA therapy (shRNA)CRISPR-based therapyRecombinase-based gene editingFluorescent reporter constructsOptogenetic reporter constructs
Industry: Non-Drug Biotech

Partnerships

Partners with top global healthcare companies as a supplier/service provider; no disclosed co-development partnerships.

Beyond the preview

Go deeper on Vector Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vector Biolabs.

Explore the full profile